Portal de Periódicos da CAPES

Is Screening With Magnetic Resonance Imaging in BRCA Mutation Carriers a Safe and Effective Alternative to Prophylactic Mastectomy?

2011; Lippincott Williams & Wilkins; Volume: 29; Issue: 13 Linguagem: Inglês

10.1200/jco.2010.32.5274

1527-7755

Monika L. Burness, Olufunmilayo I. Olopade,

Cancer Genomics and Diagnostics

Currently, many North American cooperative groups are limiting follow-up in adjuvant trials to 10 years or less because of budgetary constraints.Thus, more economic and perhaps more powerful techniques to seek these long-term end points should be explored without delay so that we may best advise women with respect to the optimal choice of long-term therapy for breast cancer.Innovative methods to continue and augment such follow-up must be developed, prioritized, and funded if important results such as those reported by Hackshaw et al 1 are to be confirmed and incorporated into practice.